
James French Hill Periodic Transaction Report
Filed Feb 4, 2025 · House Clerk · 1 transaction
U.S. Representative · R · AR-02 · All trades by James French Hill
On February 4, 2025, Rep. James French Hill (R-AR-02) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 sale) dated Jan 31, 2025.
The filing covers 1 ticker, including $CVS.
Reported amount ranges sum to $15K–$50K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 4 days.
Source document: House Clerk filing 20026706
Sample · the intelligence layer
James French Hill · Sold $CVS · Jan 31 · $15K–$50K
1 other member traded this name in the same window.
Coldpine’s read
Hill sits on House Financial Services, giving him oversight relevance to CVS's insurance and pharmacy-benefit operations. The 4-day disclosure lag is fast, meaning the market may not have fully absorbed the filing. One other member traded CVS in the same direction within 30 days, indicating minor cluster activity.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow James French Hill
Get an email the moment James French Hill files the next one. Free, no card, no spam.
Tickers in this filing
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Jan 31, 2025 | CVSCVSCVS Health Corporation Common Stock (CVS) [ST] | CVS Health Corporation Common Stock (CVS) [ST] | sell | — | $15K–$50K | 4d |
Other recent filings by James French Hill
- PTR filed Jan 23, 20264 trades · KD, PFE, SFL, SOLV
- PTR filed Jul 24, 202514 trades · MKL, BX, FTRE, INTC
- PTR filed Jan 10, 20242 trades · PYPL, SCHW
- PTR filed Dec 13, 202311 trades · PCH, FIS, INTC, MKL
- PTR filed Mar 23, 20231 trade
- PTR filed Mar 16, 20231 trade
← All congressional filings, newest first
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →